Harmon Cyrus 4

What Happened
Harmon Cyrus, a director of Olema Pharmaceuticals (OLMA), disposed of 10,000 shares on January 20, 2026. The weighted average sale price was $26.88, for a total transaction value of approximately $268,800. The sale was reported on a Form 4 filed January 21, 2026.

Key Details

• Transaction type: Sale (S) — open market or private sale reported.
• Date of transaction: 2026-01-20; Form 4 filed: 2026-01-21 (timely filed).
• Shares sold: 10,000 at a weighted average price of $26.88 (price range $26.85–$26.96).
• Total value: ~$268,800.
• Shares sold were held by Harmon Family Investors LLC; Harmon Cyrus is the manager of that entity (beneficial ownership via the LLC).
• Per the filing, a breakdown of the number of shares sold at each price is available upon request to the SEC, issuer, or any security holder.
• Shares owned after the transaction: not stated in the provided data.

Context
This was a sale of existing shares held through a family-managed LLC rather than a direct purchase or option exercise. Sales by insiders are common and do not, by themselves, indicate company prospects; they simply report disposition of holdings.